)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Adaptive Biotechnologies
Adaptive Biotechnologies (ADPT) investor relations material
Adaptive Biotechnologies TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.TD Cowen 46th Annual Health Care Conference summary2 Mar, 2026
Business performance and growth drivers
Achieved strong volume growth, guideline inclusions, and ASP improvements in 2024, with expectations to continue or exceed 30%+ volume growth in 2025.
Five key growth drivers: blood-based testing, community presence, guideline inclusion, data generation, and EMR integration, with capital allocated to the most effective areas.
Community testing is growing faster (14% in Q4) than academic centers (8-9%), with a long-term goal of 50/50 split.
EMR integration, especially repeat ordering functions, is a major growth catalyst, with early compliance rates around 63-65%.
Double-digit growth is expected for years, supported by low market penetration and stacking tailwinds from guidelines and data.
Clinical studies, guidelines, and practice impact
Multiple guideline inclusions in 2024, with a typical 6-9 month lag before impacting clinician ordering patterns.
Key studies in 2025 include MASTER-2 (maintenance therapy discontinuation in multiple myeloma), PERSEUS (MRD-directed therapy), and BOVen (CLL), with early data supporting practice-changing potential.
MIDAS study suggests MRD-negative patients in multiple myeloma may forgo transplant, reducing toxicity and changing clinical decisions.
Recurrence monitoring using MRD is gaining traction, enabling earlier intervention before clinical relapse.
Over 250 publications support the technology, reinforcing its clinical adoption.
Pricing, reimbursement, and market access
ASP increased from $1,117 to $1,307 (17%) in 2024, with a projected rise to $1,400 (7%) in 2025, driven by payer contracts and policy expansion.
Commercial payer coverage is strong in multiple myeloma (~80%), but low in DLBCL (~5%), with ongoing efforts to expand coverage.
Medicare pays for four tests per patient, while commercial payers have no such limit; efforts are underway to increase the Medicare bundle and secure recurrence monitoring reimbursement.
Total addressable market (TAM) increased by $500 million due to expanded testing opportunities.
False positive rate impact on MRD testing?
EMR integration's impact on repeat ordering?
Immune medicine business: future product potential?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Adaptive Biotechnologies earnings date
Q1 202630 Apr, 2026
Adaptive Biotechnologies
Next Adaptive Biotechnologies earnings date
Q1 202630 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Adaptive Biotechnologies Corporation operates as a commercial-stage biotechnology company. It provides immunosequencing and immunodiagnostic solutions. Furthermore the company offers research and development, and customer-focused services primarily to academic, government, pharmaceutical, biotechnology, hospital/clinical laboratories, and other companies in the United States and internationally. It operates in two segments, Adaptive Diagnostics and Adaptive Therapeutics. The company's immune system platform analyzes and interprets T cell and B cell receptor sequencing data.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage